衛教資訊

衛教資訊

:::
首頁/
衛教資訊/
衛教單張

衛教資訊

衛教資訊

衛教單張

依症狀查詢 依症狀查詢 進階搜尋 統計數據
目前搜尋條件： 英文
Azacitidine 認識化療藥品Azacitidine

Azacitidine 認識化療藥品Azacitidine

2026/07/21
Azacitidine is classified as an anticancer antimetabolites. This drug kills abnormal blood cells in bone marrow that have grown too fast and do not work properly.
Bendamustine 認識化療藥品Bendamustine

Bendamustine 認識化療藥品Bendamustine

2026/07/21
Bendamustine is an alkylating agent that exerts its anticancer activity by reacting with DNA and interfering with DNA replication and cell division. This stops the growth and spread of cancer cell in the body.
Bortezomib 認識標靶藥品Bortezomib

Bortezomib 認識標靶藥品Bortezomib

2026/07/21
Bortezomib is a proteasome inhibitor. A proteasome is an enzyme that is responsible for breaking down proteins in cells. By blocking the action of proteasome, waste proteins build up in myeloma cells, and cause them to die.
Brentuximab vedotin 認識化療藥品Brentuximab

Brentuximab vedotin 認識化療藥品Brentuximab

2026/07/21
Adcetris® is an antibody-drug conjugate combining a cytotoxic agent with a selective monoclonal antibody, which targets a protein called CD30 on the surface of some lymphoma cells, and delivers a cytotoxic agent to destroy the cancer cells.
Busulfan 認識化療藥品Busulfan

Busulfan 認識化療藥品Busulfan

2026/07/21
Busulfan is an alkylating agent that exerts its anticancer activity by reacting with DNA and interfering with DNA replication and cell division. This stops the growth and spread of cancer cell in the body.
Carfilzomib 認識化療藥品Carfilzomib

Carfilzomib 認識化療藥品Carfilzomib

2026/07/21
Carfilzomib is a proteasome inhibitor. A proteasome is an enzyme that is responsible for breaking down proteins in cells. By blocking the action of proteasome, waste proteins build up in myeloma cells, and cause them to die.
Dactinomycin 認識化療藥品Dactinomycin

Dactinomycin 認識化療藥品Dactinomycin

2026/07/21
Dactinomycin is classified as an anticancer antibiotic. This medicine inhibits DNA and RNA synthesis, thus stopping cell replication and eventually cause cell death. This cell damage slows or stops the growth of cancer cells in the body.
Daratumumab 認識化療藥品Daratumumab

Daratumumab 認識化療藥品Daratumumab

2026/07/21
Darzalex® is a monoclonal antibody that targets to the protein called CD38, which is highly expressed on multiple myeloma cells. Once Darzalex® attaches to CD38, it induces rapid cell death and activates the immune system to destroy the myeloma cells.
Daunorubicin 認識化療藥品Daunorubicin

Daunorubicin 認識化療藥品Daunorubicin

2026/07/21
Daunorubicin is classified as an anthracyline antibiotic. This medicine inhibits DNA synthesis by producing DNA cross-links which halt cell replication and eventually cause cell death. This cell damage slows or stops the growth of cancer cells in the body.
Atezolizumab 認識化療藥品Atezolizumab

Atezolizumab 認識化療藥品Atezolizumab

2026/07/21
Atezolizumab is a monoclonal antibody that binds to PD-L1 (programmed cell death ligand 1) and blocks its interaction with PD-1 (programmed cell death 1 receptor).
側邊開關圖示開關
首頁 Facebook Instagram 體系醫院 中國醫點通
▲至頂